Mapping an Agenda for Psychedelic-Assisted Therapy Research in Patients with Serious Illness April 13, 2021
Plasma BDNF concentrations and the antidepressant effects of six ketamine infusions in unipolar and bipolar depression March 29, 2021
Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes March 23, 2021
Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action March 19, 2021
Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer March 18, 2021
Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review March 7, 2021
Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property February 26, 2021
Functional connectivity between the amygdala and subgenual cingulate gyrus predicts the antidepressant effects of ketamine in patients with treatment-resistant depression February 21, 2021
First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder February 18, 2021
